Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
May 2021
Historique:
received: 09 01 2021
accepted: 10 01 2021
pubmed: 20 2 2021
medline: 19 8 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

Chronic systemic skin disease and cardiovascular disease are multisystem disorders which have been associated with each other for centuries. Recent research has strengthened this association, particularly in systemic inflammatory disease. Here we explore the current literature on psoriasis, hidradenitis suppurativa, lupus erythematosus, acanthosis nigricans, atopic dermatitis, and bullous pemphigoid. Psoriasis is a chronic inflammatory disorder that has been labeled as a risk-modifier for hyperlipidemia and coronary artery disease by the American College of Cardiology ACC lipid guidelines. Cardiovascular disease is also found at a significantly higher rate in patients with hidradenitis suppurativa and lupus erythematosus. Some associations have even been noted between cardiovascular disease and acanthosis nigricans, atopic dermatitis, and bullous pemphigoid. While many of these associations have been attributed to a shared underlying disease process such as chronic systemic inflammation and shared underlying risk factors, these dermatologic manifestations can help to identify patients at higher risk for cardiovascular disease.

Identifiants

pubmed: 33607473
pii: S0146-2806(21)00014-1
doi: 10.1016/j.cpcardiol.2021.100799
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100799

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

David A Bulger (DA)

Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN.

Sheharyar Minhas (S)

Department of Medicine, Baptist Memorial Hospital, Memphis, TN.

Abdul Aziz Asbeutah (AA)

Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN.

Sharif Kayali (S)

Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN.

Hamid A K Shirwany (HAK)

College of Medicine, University of Tennessee Health Science Center, Memphis, TN.

Jay R Patel (JR)

College of Medicine, University of Tennessee Health Science Center, Memphis, TN.

Michael Paul Seitz (MP)

Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN.

Katie Clark (K)

Kaplan-Amonette Department of Dermatology, University of Tennessee Health Science Center, Memphis, TN.

Tejesh Patel (T)

Kaplan-Amonette Department of Dermatology, University of Tennessee Health Science Center, Memphis, TN,. Electronic address: tpatel3@uthsc.edu.

Rami N Khouzam (RN)

Department of Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH